IPHYF
Price:
$1.65
Market Cap:
$146.30M
Innate Pharma S.A., a biotechnology firm based in Marseille, France, operates globally, focusing on the discovery, advancement, and commercialization of innovative antibody-based therapies, primarily targeting various oncological conditions. The company's clinical pipeline includes several promising candidates: Lacutamab (IPH4102): An anti-KIR3DL2 antibody currently undergoing Phase II clinical evaluation for cutaneous T-cell and peripheral T-cell lymphoma, as well as refractory Sézary syndrome. Monalizumab: An immune checkpoint inhibitor that has progressed to Phase III clinical trials, being investigated for its potential in treating advanced solid tumors, notably colorectal, lung, and hea...[Read more]
Industry
Biotechnology
IPO Date
2015-06-09
Stock Exchange
OTC
Ticker
IPHYF
According to Innate Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 140.78M. This represents a change of 36.51% compared to the average of 103.13M of the last 4 quarters.
The mean historical Enterprise Value of Innate Pharma S.A. over the last ten years is 210.10M. The current 140.78M Enterprise Value has changed 6.60% with respect to the historical average. Over the past ten years (40 quarters), IPHYF's Enterprise Value was at its highest in in the December 2015 quarter at 794.33M. The Enterprise Value was at its lowest in in the June 2009 quarter at 0.
Average
210.10M
Median
163.53M
Minimum
82.56M
Maximum
616.45M
Discovering the peaks and valleys of Innate Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 126.88%
Maximum Annual Enterprise Value = 616.45M
Minimum Annual Increase = -72.65%
Minimum Annual Enterprise Value = 82.56M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 137.54M | 66.60% |
| 2024 | 82.56M | -35.96% |
| 2023 | 128.91M | -18.65% |
| 2022 | 158.47M | -25.07% |
| 2021 | 211.49M | 126.88% |
| 2020 | 93.22M | -56.56% |
| 2019 | 214.61M | -25.80% |
| 2018 | 289.21M | 71.56% |
| 2017 | 168.58M | -72.65% |
| 2016 | 616.45M | 10.05% |
The current Enterprise Value of Innate Pharma S.A. (IPHYF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
116.34M
5-year avg
143.80M
10-year avg
210.10M
Innate Pharma S.A.’s Enterprise Value is greater than Botanix Pharmaceuticals Limited (44.88M), greater than NDT Pharmaceuticals Inc. (84.22M), greater than Molecular Partners AG (41.99M), less than Scancell Holdings plc (224.76M), greater than Brii Biosciences Limited (9.45M), less than Ascend Wellness Holdings, Inc. (677.70M), less than JW (Cayman) Therapeutics Co. Ltd (330.13M), less than Hofseth BioCare ASA (738.00M), less than Kintor Pharmaceutical Limited (977.35M), less than Venus Medtech (Hangzhou) Inc. (562.14M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 44.88M | $48.06M | |
| 84.22M | $84.22M | |
| 41.99M | $181.93M | |
| 224.76M | $286.61M | |
| 9.45M | $107.82M | |
| 677.70M | $107.98M | |
| 330.13M | $98.91M | |
| 738.00M | $65.82M | |
| 977.35M | $160.37M | |
| 562.14M | $186.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innate Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Innate Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Innate Pharma S.A.'s Enterprise Value?
What is the highest Enterprise Value for Innate Pharma S.A. (IPHYF)?
What is the 3-year average Enterprise Value for Innate Pharma S.A. (IPHYF)?
What is the 5-year average Enterprise Value for Innate Pharma S.A. (IPHYF)?
How does the current Enterprise Value for Innate Pharma S.A. (IPHYF) compare to its historical average?